- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Menu
Therapeutic Dostarlimab monoclonal antibody from the original Jemperli® commercial drug.
Showing all 4 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
|---|---|---|---|---|---|---|---|---|---|---|
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
07/2025 |
493,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
10/2025 |
1.355,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
10/2025 |
1.115,00 € |
||
PD-1 |
Monoclonal Antibody |
Jemperli® |
50 mg/mL |
– |
10 mg |
-80 °C |
03/2026 |
2.324,00 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin
